Cover Your Bases Campaign Kicks Off Oral
Health Month with ARESTIN (minocycline HCI) Patient Ambassador
Alex Rodriguez
LAVAL,
QC, May 31, 2023 /PRNewswire/ -- Bausch Health
Companies Inc. (NYSE/TSX: BHC) and its oral health care business,
OraPharma, today announced its collaboration with World Series
Champion, Alex Rodriguez, to launch
a national awareness campaign about the prevalence and impact of
gum disease. The Cover Your Bases campaign includes
educational content about the disease and encourages patients to
talk to their dentist about comprehensive treatment options. The
campaign launch is timed to Oral Health Month recognized throughout
June and features Alex as a patient ambassador.
Experience the full interactive Multichannel News Release here:
https://www.multivu.com/players/English/9171951-orapharma-alex-rodriguez-managing-gum-disease-awareness/
According to the American Dental Association, gum disease
affects nearly 65 million Americans nationwide. More specifically,
nearly half of Americans aged 30 and older and 70% of those aged 75
and older have some form of gum disease. The most common symptoms
of gum disease include bleeding during or after brushing and red or
swollen gums. Some studies suggest that gum disease may be
associated with an increased risk for other chronic conditions
throughout the body, such as diabetes and heart disease.
"Throughout my life and career, I've always put a great deal of
energy into prioritizing my health, which is why I was shocked when
my dentist told me I had early-stage gum disease," said Rodriguez.
"My dentist also informed me that gum disease is more common in men
and in Latino communities, which is why I felt it was really
important for me to share my story. I was lucky to catch it early,
and if it can happen to me, it can happen to anyone."
While there is no cure for gum disease, it is important to
consider comprehensive treatment plans that may include ARESTIN –
an antibiotic used in combination with scaling and root planing
(SRP) to treat adult periodontitis, also known as gum disease.
ARESTIN is applied at the site of infection, helping to fight the
bacteria that cause gum disease. ARESTIN may be used as part of an
overall health program that includes good brushing and flossing
habits and SRP.
ARESTIN should not be taken if you are allergic to minocycline
or tetracyclines. Ask your dentist or pharmacist for a list of
these drugs if you are not sure. The use of tetracycline class
drugs, including ARESTIN, during tooth development may cause
permanent discoloration of the teeth, and therefore should not be
used in children or in pregnant or nursing women. Please see below
for Additional Important Safety Information regarding ARESTIN.
"This campaign is the first of its kind for OraPharma, and we
couldn't be more excited to have Alex onboard to share his
experience not only to help educate patients about this often
misunderstood and underdiagnosed disease, but also to encourage
them to talk to their dentist," said Tom
Stern, Vice President and General Manager at OraPharma. "We
hope that this campaign will help bring awareness to gum disease
and empower others to take charge of their dental health by seeking
out appropriate treatment options that may help manage this serious
disease."
To learn more about a treatment option and to hear Alex's story,
visit www.Arestin.com.
About ARESTIN®
INDICATION
ARESTIN® (minocycline HCl) Microspheres,
1mg is used in combination with scaling and root planing (SRP)
procedures to treat patients with adult periodontitis (gum
disease). ARESTIN® may be used as part of an overall oral health
program that includes good brushing and flossing habits and
SRP.
IMPORTANT SAFETY INFORMATION
- Do not take ARESTIN if you are allergic to minocycline or
tetracyclines. Ask your dentist or pharmacist for a list of these
drugs if you are not sure. Swelling of the face, itching of the
skin, fever and enlarged lymph nodes have been reported with the
use of ARESTIN. Some of these reactions were serious. Tell your
dentist right away if you have any signs of allergic reaction, such
as skin reactions or trouble breathing, or if you have an
exaggerated sunburn reaction.
- THE USE OF TETRACYCLINE CLASS DRUGS, INCLUDING ARESTIN, DURING
TOOTH DEVELOPMENT MAY CAUSE PERMANENT DISCOLORATION OF THE TEETH,
AND THEREFORE SHOULD NOT BE USED IN CHILDREN OR IN PREGNANT OR
NURSING WOMEN.
- ARESTIN has not been studied in patients with weakened immune
systems (such as patients with HIV infections or diabetes, or those
receiving chemotherapy or radiation). Tetracyclines, including oral
minocycline, have been associated with the development of
autoimmune syndrome with symptoms such as joint pain, muscle pain,
rash, swelling, fever, enlarged lymph nodes, and general body
weakness. Tell your doctor about any health problems you have,
including whether you have had oral candidiasis ("thrush") in the
past, and about all medications you are taking.
- In clinical studies, the most frequently reported non-dental
side effects were headache, infection, flu symptoms, and pain.
You are encouraged to report negative side effects of
prescription drugs to the FDA. Visit www.fda.gov/medwatch or call
1-800-FDA-1088.
Click here for full Prescribing Information.
About OraPharma
OraPharma is a specialty
pharmaceutical company committed to partnering with dental
professionals to improve oral health. Founded more than 25 years
ago, OraPharma includes a curated portfolio of treatments for
periodontal disease, malocclusion and multiple regenerative
solutions for oral surgery. More information can be found at
https://www.orapharma.com/.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global diversified pharmaceutical company
whose mission is to improve people's lives with our health care
products. We develop, manufacture and market a range of products
primarily in gastroenterology, hepatology, neurology, dermatology,
international pharmaceuticals and eye health, through our
controlling interest in Bausch + Lomb. With our leading durable
brands, we are delivering on our commitments as we build an
innovative company dedicated to advancing global health. For more
information, visit www.bauschhealth.com and connect with us on
Twitter and LinkedIn.
ARE.0118.USA.23
View original
content:https://www.prnewswire.com/news-releases/orapharma-and-alex-rodriguez-team-up-to-raise-awareness-about-the-importance-of-managing-gum-disease-301837677.html
SOURCE OraPharma
